Skip to main content
logo
Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.230
-0.070 (-1.63%)
Jul 20, 2026, 4:00 PM EDT - Market closed

Treace Medical Concepts Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
207.32212.69209.36187.12141.8494.42
Revenue Growth (YoY)
-1.66%1.59%11.88%31.92%50.22%64.59%
Cost of Revenue
42.0542.9441.0935.1825.5316.89
Gross Profit
165.27169.75168.26151.94116.3177.53
Selling, General & Admin
201.66203.62203.36187.93137.5783.84
Research & Development
19.3420.2820.5915.4413.5810.2
Total Operating Expenses
221.01223.91223.95203.37151.1594.04
Operating Income
-55.74-54.15-55.69-51.43-34.84-16.51
Interest Income
2.442.784.886.731.310.02
Interest Expense
-5.58-5.32-5.26-5.17-4.4-4.06
Other Non-Operating Income (Expense)
-4.73-7.150.272.24-12.86-4.04
Total Non-Operating Income (Expense)
-7.87-9.7-0.113.8-15.94-8.08
Pretax Income
-63.61-63.85-55.8-47.63-50.79-24.59
Net Income
-61.04-59-55.74-49.53-42.82-20.55
Net Income Attributable to Preferred Dividends
-----0.2
Net Income to Common
-61.04-59-55.74-49.53-42.82-20.75
Shares Outstanding (Basic)
646362615548
Shares Outstanding (Diluted)
646362615548
Shares Change (YoY)
2.27%1.86%2.07%10.09%14.17%30.61%
EPS (Basic)
-0.97-0.93-0.90-0.81-0.77-0.43
EPS (Diluted)
-0.97-0.93-0.90-0.81-0.77-0.43
Free Cash Flow
-25.96-29.49-48.76-46.03-45.49-19.9
Free Cash Flow Per Share
-0.41-0.47-0.79-0.76-0.82-0.41
Gross Margin
79.72%79.81%80.37%81.20%82.00%82.11%
Operating Margin
-26.89%-25.46%-26.60%-27.48%-24.57%-17.49%
Profit Margin
-29.44%-27.74%-26.63%-26.47%-30.19%-21.77%
FCF Margin
-12.52%-13.86%-23.29%-24.60%-32.07%-21.07%
EBITDA
-46.68-43.53-47.27-46.08-32.71-15.83
EBITDA Margin
-22.52%-20.47%-22.58%-24.62%-23.06%-16.76%
EBIT
-55.74-54.15-55.69-51.43-34.84-16.51
EBIT Margin
-26.89%-25.46%-26.60%-27.48%-24.57%-17.49%
SEC Filings: 10-K · 10-Q